SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Hoes Arno) "

Sökning: WFRF:(Hoes Arno)

  • Resultat 1-10 av 42
  • [1]2345Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  • Hogenhuis, Jochem, et al. (författare)
  • Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure.
  • 2007
  • Ingår i: European Journal of Heart Failure. - 1388-9842 .- 1879-0844. ; 9:8, s. 787-94
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Anaemia may affect B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) levels, but this has not been well described in heart failure (HF) patients without the exclusion of patients with renal dysfunction. AIMS: To study the influence of both anaemia and renal function on BNP and NT-proBNP levels in a large group of hospitalised HF patients. METHODS AND RESULTS: We studied 541 patients hospitalised for HF (mean age 71+/-11 years, 62% male, and left ventricular ejection fraction 0.33+/-0.14). Of these patients, 30% (n=159) were anaemic (women: Hb<7.5 mmol/l, men: Hb<8.1 mmol/l). Of the 159 anaemic patients, 73% had renal dysfunction (eGFR<60 ml/min/1.73 m2) and of the non-anaemic patients, 57% had renal dysfunction. BNP and NT-proBNP levels were measured in all patients before discharge. In multivariable analyses both plasma haemoglobin and eGFR were independently related to the levels of BNP and NT-proBNP (standardised beta's of -0.16, -0.14 [BNP] and -0.19, -0.26 [NT-proBNP] respectively, P-values<0.01). CONCLUSION: Anaemia and renal dysfunction are related to increased BNP and NT-proBNP levels, independent of the severity of HF. These results indicate that both anaemia and renal dysfunction should be taken into consideration during the interpretation of BNP and NT-proBNP levels in HF patients.
  •  
8.
  • Hogenhuis, Jochem, et al. (författare)
  • Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
  • 2006
  • Ingår i: American Heart Journal. - 0002-8703 .- 1097-6744. ; 151:5, s. 1012.e1-5
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: In patients with acute heart failure (HF) presenting at the emergency department, a B-type natriuretic peptide (BNP) level < 100 pg/mL was found in only 10% of the patients. However, in a more stable outpatient HF population from another study, a BNP level < 100 pg/mL was found in as many as 21% of the patients. Therefore, we aimed to investigate the prevalence and characteristics of stabilized patients with BNP levels < 100 pg/mL before discharge after admission for decompensated heart failure HF. METHODS: We investigated 601 patients with HF who were part of a large-scale multicenter study in The Netherlands. All patients had been admitted for decompensated HF, and their BNP levels were measured before discharge when they had been clinically stabilized. Clinical characteristics of patients with BNP levels < 100 and > or = 100 pg/mL were compared. RESULTS: Patients were 70 +/- 12 years old, 61% were men, and mean left ventricular ejection fraction was 0.34 +/- 0.14. Of these patients, 10% had BNP levels < 100 pg/mL. Patients with a BNP level < 100 pg/mL were similar in age and sex but had higher left ventricular ejection fraction (0.41 +/- 0.14 vs 0.33 +/- 0.13, P < .001), body mass index, and hemoglobin and hematocrit concentrations compared with those with BNP levels > or = 100 pg/mL. CONCLUSIONS: In clinically stable patients with a recent admission for decompensated HF, only 10% had BNP levels > or = 100 pg/mL. These patients with low BNP levels seemed to have less severe HF and more frequently had preserved systolic function compared with patients with BNP levels > or = 100 pg/mL.
  •  
9.
  • Jaarsma, Tiny, et al. (författare)
  • Effect of moderate or intensive disease management program on outcome in patients with heart failure : Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).
  • 2008
  • Ingår i: Archives of Internal Medicine. - 0003-9926 .- 1538-3679. ; 168:3, s. 316-24
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Heart failure (HF) disease management programs are widely implemented, but data about their effect on outcome have been inconsistent. METHODS: The Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) was a multicenter, randomized, controlled trial in which 1023 patients were enrolled after hospitalization because of HF. Patients were assigned to 1 of 3 groups: a control group (follow-up by a cardiologist) and 2 intervention groups with additional basic or intensive support by a nurse specializing in management of patients with HF. Patients were studied for 18 months. Primary end points were time to death or rehospitalization because of HF and the number of days lost to death or hospitalization. RESULTS: Mean patient age was 71 years; 38% were women; and 50% of patients had mild HF and 50% had moderate to severe HF. During the study, 411 patients (40%) were readmitted because of HF or died from any cause: 42% in the control group, and 41% and 38% in the basic and intensive support groups, respectively (hazard ratio, 0.96 and 0.93, respectively; P = .73 and P = .52, respectively). The number of days lost to death or hospitalization was 39 960 in the control group, 33 731 days for the basic intervention group (P = .81), and 34 268 for the intensive support group (P = .49). All-cause mortality occurred in 29% of patients in the control group, and there was a trend toward lower mortality in the intervention groups combined (hazard ratio, 0.85; 95% confidence interval, 0.66-1.08; P = .18). There were slightly more hospitalizations in the 2 intervention groups (basic intervention group, P = .89; and intensive support group, P = .60). CONCLUSIONS: Neither moderate nor intensive disease management by a nurse specializing in management of patients with HF reduced the combined end points of death and hospitalization because of HF compared with standard follow-up. There was a nonsignificant, potentially relevant reduction in mortality, accompanied by a slight increase in the number of short hospitalizations in both intervention groups. Clinical Trial Registry http://trialregister.nl Identifier: NCT 98675639.
  •  
10.
  • Jaarsma, Tiny, et al. (författare)
  • Effects of exergaming on exercise capacity in patients with heart failure : results of an international multicentre randomized controlled trial
  • 2021
  • Ingår i: European Journal of Heart Failure. - : John Wiley & Sons. - 1388-9842 .- 1879-0844. ; 23:1, s. 114-124
  • Tidskriftsartikel (refereegranskat)abstract
    • AimsExergaming is a new tool to increase physical activity. This study aimed to determine the effects of access to a home‐based exergame (Nintendo Wii) in patients with heart failure (HF) on exercise capacity, self‐reported physical activity and patient‐reported outcome measures.Methods and resultsWe enrolled 605 HF patients in New York Heart Association functional class I–IV, independent of ejection fraction, in an international multicentre randomized controlled trial. Patients were randomized to exergame (intervention) or motivational support (control). The primary endpoint was change in submaximal aerobic exercise capacity as measured by the distance walked in 6 min (6MWT) between baseline and 3 months. Secondary endpoints included long‐term submaximal aerobic exercise capacity, muscle function, self‐reported physical activity, exercise motivation, exercise self‐efficacy at 3, 6 and 12 months. At baseline, patients on average walked 403 ± 142 m on the 6MWT. Patients in the exergame group walked further compared to controls at 3 months (454 ± 123 vs. 420 ± 127 m, P = 0.005), at 6 months (452 ± 123 vs. 426 ± 133 m, P = 0.015) and 12 months (456 ± 122 vs. 420 ± 135 m, P = 0.004). However, correcting for baseline 6MWT values by means of a linear mixed‐effects model revealed no main effect for the intervention on 6MWT. Small significant effects on muscle function were found. Statistically significant treatment effects were found for muscle function but after correction for baseline and confounders, only the treatment effect for the heel‐rise left at 6 months was significant (P < 0.05). No treatment effect was found for exercise motivation, exercise self‐efficacy, or self‐reported physical activity.ConclusionExergaming was safe and feasible in patients with HF with different profiles in different health care systems, cultures and climates. However, it was not effective in improving outcomes on submaximal aerobic exercise capacity. Subgroup analysis did not identify specific subgroups benefiting from the intervention.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 42
  • [1]2345Nästa
Typ av publikation
tidskriftsartikel (39)
forskningsöversikt (2)
recension (1)
Typ av innehåll
refereegranskat (40)
övrigt vetenskapligt (2)
Författare/redaktör
Jaarsma, Tiny (28)
Hoes, Arno (18)
Dickstein, Kenneth (12)
Reiner, Željko (10)
Piepoli, Massimo F. (9)
Dean, Veronica (8)
visa fler...
Deaton, Christi (8)
van Veldhuisen, Dirk ... (8)
Fagard, Robert (8)
Funck-Brentano, Chri ... (8)
Strömberg, Anna (7)
Tendera, Michal (7)
Ryden, Lars (6)
Atar, Dan (6)
Kolh, Philippe (6)
Knuuti, Juhani (6)
Torbicki, Adam (6)
Windecker, Stephan (6)
Zamorano, Jose Luis (6)
Ponikowski, Piotr (6)
Hillege, Hans L. (6)
De Backer, Guy (6)
Hasdai, David (6)
Baumgartner, Helmut (6)
Sechtem, Udo (6)
Ceconi, Claudio (6)
Filippatos, Gerasimo ... (5)
McMurray, John J V (5)
Bax, Jeroen J (5)
Cifkova, Renata (5)
Kirchhof, Paulus (5)
Widimsky, Petr (4)
Lancellotti, Patrizi ... (4)
McDonagh, Theresa (4)
Butler, Javed (4)
Anker, Stefan D (4)
Voors, Adriaan A. (4)
Perk, Joep (4)
Zannad, Faiez (4)
Chioncel, Ovidiu (4)
Metra, Marco (4)
Mebazaa, Alexandre (4)
Lam, Carolyn S P (4)
Ebrahim, Shah (4)
Perk, Joep, 1945- (4)
Komajda, Michel (4)
Crespo-Leiro, Maria ... (4)
Graham, Ian (4)
Swedberg, Karl (4)
Moulin, Cyril (4)
visa färre...
Lärosäte
Linköpings universitet (30)
Karolinska Institutet (9)
Linnéuniversitetet (7)
Jönköping University (4)
Göteborgs universitet (3)
Uppsala universitet (3)
Språk
Engelska (41)
Spanska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (20)
Samhällsvetenskap (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy